Last reviewed · How we verify
NCT07292766
Metabolomic Profiling of Patients With Traumatic Brain Injury
trial in Traumatic Brain Injury in 60 participants. Currently enrolling.
1 December 2025
Quick facts
| Lead sponsor | Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 60 |
| Start date | 1 February 2024 |
| Primary completion | 1 December 2025 |
| Estimated completion | 1 February 2026 |
| Sites | 1 location across Turkey (Türkiye) |
Conditions studied
- Traumatic Brain Injury — all drugs for Traumatic Brain Injury →
- Traumatic Brain Injury (TBI) Patients — all drugs for Traumatic Brain Injury (TBI) Patients →
Sponsor
Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital
Who can join
Adults 18 to 65, any sex, with Traumatic Brain Injury or Traumatic Brain Injury (TBI) Patients. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Traumatic Brain Injury (TBI) is a significant cause of mortality and morbidity worldwide. However, the literature on determining its severity and predicting prognosis is insufficient. This study aimed to examine the differences in metabolite levels between trauma patients with severe TBI and orthopedic trauma patients without brain injury.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07292766
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Traumatic Brain Injury
Currently open trials in the same condition.
- NCT07176936 — Improving Speech in Noise Using Noninvasive Stimulation · NA · recruiting
- NCT07473505 — Integrative Bilateral Cervical Sympathetic Blocks for Trauma-Related Symptoms in Special Operations Veterans: A Prospect · recruiting
- NCT07455136 — A Study to Develop a Blood-based Test for Aiding the Diagnosis/Prognosis of Traumatic Brain Injury in Adults and for Mon · recruiting
- NCT07404761 — Safety and Effectiveness of Spatial StimelMD (SSMD) in Subjects With Upper Limb Neuromotor Impairments · NA · recruiting
- NCT07230002 — Effects of Moderate/Severe Traumatic Brain Injury in the Subacute or Chronic Phase on Locomotor Strategies Involved in N · NA · recruiting
Other Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital trials
Trials by the same sponsor.
- NCT07394816 — Can Ultrasound-Guided Fascial Plane Blocks Reduce Postoperative Pulmonary Complications After Major Abdominal Surgery? · not yet recruiting
- NCT07509697 — Artificial Intelligence-Based Evaluation of Chest X-Rays in Ventilator-Associated Pneumonia · completed
- NCT07440095 — Mortality Predictors in Patients 80+ After Major Abdominal Surgery: Role of Frailty and Physiological Reserve · not yet recruiting
- NCT07392086 — Comparison of FCV and VCV in One-Lung Ventilation · recruiting
- NCT07325617 — Tracking AI/LLM Literacy and Knowledge in Urology Outpatients (TALK-U) · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07292766 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital
- Last refreshed: 18 December 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07292766.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing